{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:20:56Z","timestamp":1783178456590,"version":"3.54.6"},"publisher-location":"Chichester, UK","reference-count":98,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd008559.pub2","type":"reference-entry","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T18:37:25Z","timestamp":1346783845000},"source":"Crossref","is-referenced-by-count":40,"title":["Atypical antipsychotics for disruptive behaviour disorders in children and youths"],"prefix":"10.1002","author":[{"given":"Jik H","family":"Loy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally N","family":"Merry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E","family":"Hetrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Stasiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,9,12]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD008559.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/1044546041649020","article-title":"Risperidone effects in the presence\/absence of psychostimulant medicine in children in ADHD, other disruptive disorders and subaverage IQ","volume":"14","author":"Aman","year":"2004","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD008559.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1176\/appi.ajp.159.8.1337","article-title":"Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence","volume":"159","author":"Aman","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD008559.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/chi.0b013e3180323354","article-title":"Risperidone augmentation for treatment-resistant aggression in attention-deficit\/hyperactivity disorder: a placebo-controlled pilot study","volume":"46","author":"Armenteros","year":"2007","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4088\/JCP.v62n0405","article-title":"A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities","volume":"62","author":"Buitelaar","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/cap.2006.0007","article-title":"Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder","volume":"18","author":"Connor","year":"2008","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00004583-200004000-00021","article-title":"A double-blind pilot study of risperidone in the treatment of conduct disorder","volume":"39","author":"Findling","year":"2000","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1176\/appi.ajp.163.3.402","article-title":"A randomized, double-blind, placebo-controlled study of risperidone maintenance treatment in children and adolescents With disruptive behavior disorders","volume":"163","author":"Reyes","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/1044546041649020","article-title":"Risperidone effects in the presence\/absence of psychostimulant medicine in children in ADHD, other disruptive disorders and subaverage IQ","volume":"14","author":"Aman","year":"2004","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD008559.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.yic.0000166403.03732.72","article-title":"Risperidone reduces aggression in boys with disruptive behaviour disorder and below average intelligence quotient: analysis of two placebo-controlled randomized trials","volume":"20","author":"LeBlanc","year":"2005","journal-title":"International Clinical Psychopharmacology"},{"issue":"9","key":"10.1002\/14651858.CD008559.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00004583-200209000-00002","article-title":"Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs","volume":"41","author":"Snyder","year":"2002","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/104454601750143348","article-title":"Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial","volume":"11","author":"Bellinghen","year":"2001","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD008559.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/cap.2000.10.19","article-title":"Open-label treatment with risperidone of 26 psychiatrically hospitalized children and adolescents with mixed diagnoses and aggressive behavior","volume":"10","author":"Buitelaar","year":"2000","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD008559.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/01.chi.0000145805.24274.09","article-title":"Risperidone in children with disruptive behavior disorders and subaverage intelligence: a 1 year open label of 504 patients","volume":"44","author":"Croonenberghs","year":"2005","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1176\/appi.ajp.161.4.677","article-title":"Long term open label study of risperidone in children with severe disruptive behavior disorders and below average IQ","volume":"161","author":"Findling","year":"2004","journal-title":"American Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD008559.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/01.chi.0000219832.23849.31","article-title":"Effectiveness, safety and pharmacokinetics of quetiapine in aggressive children with conduct disorder","volume":"45","author":"Findling","year":"2006","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/cap.2007.0098","article-title":"Treating disruptive behavior disorders with risperidone: a 1-year, open-label safety study in children and adolescents","volume":"18","author":"Haas","year":"2008","journal-title":"Journal of Child Adolescent Psychopharmacology"},{"issue":"8","key":"10.1002\/14651858.CD008559.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/01.chi.0000223312.48406.6e","article-title":"Open-label prospective trial of olanzapine in adolescents with subaverage intelligence and disruptive behavior disorders","volume":"45","author":"Handen","year":"2006","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.eurpsy.2004.11.010","article-title":"Olanzapine treatment in adolescents with severe conduct disorder","volume":"21","author":"Masi","year":"2006","journal-title":"European Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00787-006-0504-0","article-title":"Long term safety and efficacy of risperidone in children with disruptive behaviour disorder: results of a 2-year extensive study","volume":"15","author":"Reyes","year":"2006","journal-title":"European Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00787-002-0265-3","article-title":"A clinical case series of six extremely aggressive youths treated with olanzapine","volume":"11","author":"Soderstrom","year":"2002","journal-title":"European Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1542\/peds.110.3.e34","article-title":"Long term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs","volume":"110","author":"Turgay","year":"2002","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD008559.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(08)60072-0","article-title":"Risperidone, haloperidol and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial","volume":"371","author":"Tyrer","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008559.pub2-BIB23|cit23","unstructured":"NCT00676429 Ziprasidone for severe conduct and other disruptive behavior disorders http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00676429?term=severe+conduct&rank=1"},{"key":"10.1002\/14651858.CD008559.pub2-BIB24|cit24","unstructured":"NCT00796302 Treatment of Severe Childhod Aggression (the TOSCA Study) http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00796302?term=severe+childhood+aggression&rank=1"},{"key":"10.1002\/14651858.CD008559.pub2-BIB25|cit25","volume-title":"Manual for the Child Behavior Checklist\/4-18 and 1991 Profile","author":"Achenbach","year":"1991"},{"issue":"5","key":"10.1002\/14651858.CD008559.pub2-BIB26|cit26","first-page":"485","article-title":"The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects","volume":"89","author":"Aman","year":"1985","journal-title":"American Journal of Mental Deficiency"},{"issue":"5","key":"10.1002\/14651858.CD008559.pub2-BIB27|cit27","first-page":"492","article-title":"Psychometric characteristics of the aberrant behavior checklist","volume":"89","author":"Aman","year":"1985","journal-title":"American Journal of Mental Deficiency"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0891-4222(95)00039-9","article-title":"The Nisonger CBRF: a child behavior rating form for children with developmental disabilities","volume":"17","author":"Aman","year":"1996","journal-title":"Research in Developmental Disabilities"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/1044546041649020","article-title":"Risperidone effects in the presence\/absence of psychostimulant medicine in children in ADHD, other disruptive disorders and subaverage IQ","volume":"14","author":"Aman","year":"2004","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD008559.pub2-BIB30|cit30","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSMIV-TR)","year":"2000"},{"key":"10.1002\/14651858.CD008559.pub2-BIB31|cit31","volume-title":"Publication Manual of the American Psychological Association","year":"2009"},{"key":"10.1002\/14651858.CD008559.pub2-BIB32|cit32","volume-title":"Attention-deficit Hyperactivity Disorder: a Handbook for Diagnosis and Treatment","author":"Barkley","year":"2006"},{"issue":"9","key":"10.1002\/14651858.CD008559.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/00004583-199609000-00017","article-title":"Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a four year follow up study of children with ADHD","volume":"35","author":"Biederman","year":"1996","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD008559.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1017\/S0033291707002668","article-title":"The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10 year prospective longitudinal follow-up study","volume":"38","author":"Biederman","year":"2008","journal-title":"Psychological Medicine"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pcl.2010.11.002","article-title":"Psychopharmacologic control of aggression and violence in children and adolescents","volume":"58","author":"Calles","year":"2011","journal-title":"Pediatric Clinics of North America"},{"issue":"5","key":"10.1002\/14651858.CD008559.pub2-BIB36|cit36","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009043.pub2","article-title":"Aripiprazole for autism spectrum disorders (ASD)","author":"Ching","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1469-7610.1993.tb01094.x","article-title":"An epidemiological study of disorders in late childhood and adolescence: age and gender-specific prevalence","volume":"34","author":"Cohen","year":"1993","journal-title":"Journal of Child Psychology and Psychiatry and Allied Disciplines"},{"issue":"10","key":"10.1002\/14651858.CD008559.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/00004583-200310000-00006","article-title":"Ten year review of rating scales VI: scales assessing externalising behaviors","volume":"42","author":"Collett","year":"2003","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub2-BIB39|cit39","volume-title":"Manual for Conners' Rating Scales","author":"Conners","year":"1989"},{"issue":"5","key":"10.1002\/14651858.CD008559.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/DBP.0b013e3181e121bd","article-title":"A review of attention-deficit\/hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder","volume":"31","author":"Connor","year":"2010","journal-title":"Journal of Developmental & Behavioral Pediatrics"},{"issue":"16","key":"10.1002\/14651858.CD008559.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1001\/jama.2009.1549","article-title":"Cardiometabolic risk of second generation antipsychotic medications during first time use in children and adolescents","volume":"302","author":"Correll","year":"2009","journal-title":"Journal of American Medical Association"},{"key":"10.1002\/14651858.CD008559.pub2-BIB42|cit42","unstructured":"Correll CU Antipsychotic use in youth http:\/\/www.medscape.com\/viewarticle\/718519?src=mp&spon=12&uac=123108CX"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub2-BIB43|cit43","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1097\/00004583-199604000-00014","article-title":"Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study","volume":"35","author":"Cueva","year":"1996","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub2-BIB44|cit44","first-page":"273","article-title":"Psychotropic medication utilization in a child and adolescent mental health service","volume":"16","author":"Dean","year":"2006","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/070674370705200605","article-title":"Survey of atypical antipsychotic prescribing by Canadian child psychiatrists and developmental paediatricians for patients aged 18 years","volume":"52","author":"Doey","year":"2007","journal-title":"Canadian Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD008559.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1176\/appi.ajp.157.5.818","article-title":"Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design","volume":"157","author":"Donovan","year":"2000","journal-title":"American Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD008559.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphic test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008559.pub2-BIB48|cit48","unstructured":"European Medicines Agency European Medicines Agency decision P\/167\/2011 http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/PIP_decision\/WC500110116.pdf 2011"},{"key":"10.1002\/14651858.CD008559.pub2-BIB49|cit49","unstructured":"FDA US Food and Drug Administration http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/PediatricAdvisoryCommittee\/UCM193200.pdf"},{"key":"10.1002\/14651858.CD008559.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/1469-7610.00414","article-title":"Early conduct problems and later life opportunities","volume":"39","author":"Fergusson","year":"1998","journal-title":"Journal of Child Psychology and Psychiatry and Allied Disciplines"},{"key":"10.1002\/14651858.CD008559.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1469-7610.2004.00387.x","article-title":"Show me the child at seven: the consequences of conduct problems in childhood for psychosocial functioning in adulthood","volume":"46","author":"Fergusson","year":"2004","journal-title":"Journal of Child Psychology and Psychiatry and Allied Disciplines"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD008559.pub2-BIB52|cit52","first-page":"9","article-title":"Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents","volume":"69","author":"Findling","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1176\/appi.ajp.159.7.1214","article-title":"Psychiatric comorbidity, family dysfunction and social impairment on referred youth with oppositional defiant disorder","volume":"159","author":"Greene","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/01.CHI.0000046841.56865.37","article-title":"Review of safety assessment methods used in pediatric psychopharmacology","volume":"42","author":"Greenhill","year":"2003","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub2-BIB55|cit55","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00004583-200203000-00003","article-title":"Development, reliability, and validity of the Children's Aggression Scale - Parent Version","volume":"41","author":"Halperin","year":"2002","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/01.CHI.0000046899.27264.EB","article-title":"Reliability, validity, and preliminary normative data for the Children's Aggression Scale - Teacher Version","volume":"42","author":"Halperin","year":"2003","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s002130050410","article-title":"Central 5-HT depletion enhances impulsive responding without affecting the accuracy of attentional performance: interactions with dopaminergic mechanisms","volume":"133","author":"Harrison","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD008559.pub2-BIB58|cit58","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2165\/00002018-200730070-00002","article-title":"Safety and usage of atypical antipsychotic medicines in children, a nationwide prospective cohort study","volume":"30","author":"Harrison-Woolrych","year":"2007","journal-title":"Drug Safety"},{"issue":"11","key":"10.1002\/14651858.CD008559.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1176\/appi.ajp.2009.08111747","article-title":"Randomized, single-blind, controlled trial of a specialist behavior therapy team for challenging behavior in adults with intellectual disabilities","volume":"166","author":"Hassiotis","year":"2009","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub2-BIB60|cit60","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD008559.pub2-BIB61|cit61","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD008559.pub2-BIB62|cit62","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","article-title":"What is meant by intention to treat analysis? Survey of published randomised controlled trials","volume":"319","author":"Hollis","year":"1999","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008559.pub2-BIB63|cit63","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00213-006-0537-6","article-title":"Systematic review of pharmacotherapy of disruptive behaviour disorders in children and adolescents","volume":"191","author":"Ipser","year":"2007","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD008559.pub2-BIB64|cit64","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/chi.0b013e31802f1454","article-title":"Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies","volume":"46","author":"Jensen","year":"2007","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub2-BIB65|cit65","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00787-006-0580-1","article-title":"Management of psychiatric disorders in children and adolescents with atypical antipsychotics, a systematic review of published clinical trials","volume":"16","author":"Jensen","year":"2007","journal-title":"European Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10802-007-9201-9","article-title":"A meta-analytic review of components associated with parent training program effectiveness","volume":"36","author":"Kaminski","year":"2008","journal-title":"Journal of Abnormal Child Psychology"},{"key":"10.1002\/14651858.CD008559.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1475-3588.2007.00460.x","article-title":"Evidence for interventions for young offenders","volume":"12","author":"Karnik","year":"2007","journal-title":"Child and Adolescent Mental Health"},{"key":"10.1002\/14651858.CD008559.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00005053-198809000-00007","article-title":"Profiles of aggression among psychiatric patients: I. nature and prevalence","volume":"176","author":"Kay","year":"1988","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"10","key":"10.1002\/14651858.CD008559.pub2-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/00004583-199710000-00016","article-title":"Parent management training: evidence, outcomes and issues","volume":"36","author":"Kazdin","year":"1997","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub2-BIB70|cit70","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00004583-199305000-00013","article-title":"Treatment of aggressive children with clonidine: results of an open pilot study","volume":"32","author":"Kemph","year":"1993","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub2-BIB71|cit71","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004797.pub4","article-title":"Multisystemic therapy for social, emotional, and behavioral problems in youth aged 10-17","author":"Littell","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub2-BIB72|cit72","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006561","article-title":"Functional Family Therapy for families of youth (age 11-18) with behaviour problems (Protocol)","author":"Littell","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008559.pub2-BIB73|cit73","doi-asserted-by":"crossref","DOI":"10.4324\/9781410602930","volume-title":"Antisocial Behavior and Mental Health Problems: Explanatory Factors in Childhood and Adolescence","author":"Loeber","year":"1998"},{"key":"10.1002\/14651858.CD008559.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1017\/S0954579402001104","article-title":"Males on the life-course persistent and adolescence-limited antisocial pathway: follow up at age 26","volume":"14","author":"Moffitt","year":"2002","journal-title":"Development and Psychopathology"},{"key":"10.1002\/14651858.CD008559.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub2-BIB76|cit76","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00004583-200202000-00004","article-title":"Ten year review of rating scales I: overview of scale functioning, psychometric properties and selection","volume":"41","author":"Myers","year":"2002","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub2-BIB77|cit77","first-page":"13","article-title":"Trends in antipsychotic drug use by very young privately insured children","volume":"49","author":"Olfson","year":"2010","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub2-BIB78|cit78","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1542\/peds.2008-3782","article-title":"Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder","volume":"124","author":"Owen","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub2-BIB79|cit79","first-page":"27","article-title":"Pharmacotherapy of aggression in children and adolescents: efficacy and effect size","volume":"15","author":"Pappadopulos","year":"2006","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1753-2000-4-9","article-title":"Controversies concerning the diagnosis and treatment of bipolar disorder in children","volume":"4","author":"Parens","year":"2010","journal-title":"Child and Adolescent Psychiatry and Mental Health"},{"issue":"6","key":"10.1002\/14651858.CD008559.pub2-BIB81|cit81","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/cap.2010.0145","article-title":"The pharmacoepidemiology of antipsychotic medications for canadian children and adolescents: 2005-2009","volume":"21","author":"Pringsheim","year":"2011","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"10.1002\/14651858.CD008559.pub2-BIB82|cit82","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1542\/peds.2007-2008","article-title":"Epidemiologic feature of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom","volume":"121","author":"Rani","year":"2008","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD008559.pub2-BIB83|cit83","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"issue":"2","key":"10.1002\/14651858.CD008559.pub2-BIB84|cit84","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00004583-200302000-00007","article-title":"Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part 1: A review","volume":"42","author":"Schur","year":"2003","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub2-BIB85|cit85","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1192\/apt.bp.106.002626","article-title":"An update on interventions for conduct disorder","volume":"14","author":"Scott","year":"2008","journal-title":"Advances in Psychiatric Treatment"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00004583-200101000-00014","article-title":"Infant and toddler pathways leading to early externalizing disorders","volume":"40","author":"Shaw","year":"2001","journal-title":"Journal of American Academy of Child and Adolescent Psychiatry"},{"issue":"Suppl 10","key":"10.1002\/14651858.CD008559.pub2-BIB87|cit87","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.1097\/00004583-199710001-00008","article-title":"Practice parameters for the assessment and treatment of children and adolescents with conduct disorder","volume":"36","author":"Steiner","year":"1997","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD008559.pub2-BIB88|cit88","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1017\/S1092852900018514","article-title":"Psychopharmacologic strategies for the treatment of aggression in juveniles","volume":"8","author":"Steiner","year":"2003","journal-title":"CNS Spectrums"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub2-BIB89|cit89","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.chi.0000246060.62706.af","article-title":"Practice parameters for the assessment and treatment of children and adolescents with oppositional defiant disorder","volume":"46","author":"Steiner","year":"2007","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub2-BIB90|cit90","first-page":"157","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"339","author":"Sterne","year":"2009","journal-title":"British Medical Journal"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD008559.pub2-BIB91|cit91","first-page":"26","article-title":"Neuroreceptor mechanisms of aggression and its treatment","volume":"64","author":"Swann","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD008559.pub2-BIB92|cit92","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0891-4222(95)00037-2","article-title":"The Nisonger child behavior rating form: age and gender effect and norms","volume":"17","author":"Tasse","year":"1996","journal-title":"Research in Developmental Disabilities"},{"key":"10.1002\/14651858.CD008559.pub2-BIB93|cit93","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2165\/00023210-200620070-00002","article-title":"Pharmacological aspects of the treatment of conduct disorder in children and adolescents","volume":"20","author":"Tcheremissine","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD008559.pub2-BIB94|cit94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1192\/apt.bp.105.000901","article-title":"Child psychiatry and its relationship with the pharmaceutical industry: theoretical and practical issues","volume":"14","author":"Timimi","year":"2008","journal-title":"Advances in Psychiatric Treatment"},{"key":"10.1002\/14651858.CD008559.pub2-BIB95|cit95","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1023\/A:1020867831811","article-title":"Reactive aggression in boys with disruptive behaviour disorders: behaviour, physiology and affect","volume":"30","author":"Waschbusch","year":"2002","journal-title":"Journal of Abnormal Child Psychology"},{"key":"10.1002\/14651858.CD008559.pub2-BIB96|cit96","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1017\/CBO9780511734960.012","volume-title":"Psychotherapy for Children and Adolescents, Evidence-Based Treatments and Case Examples","author":"Weisz","year":"2004"},{"key":"10.1002\/14651858.CD008559.pub2-BIB97|cit97","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1191\/1740774504cn032oa","article-title":"Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals","volume":"1","author":"Wood","year":"2004","journal-title":"Clinical Trials"},{"issue":"1","key":"10.1002\/14651858.CD008559.pub2-BIB98|cit98","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1176\/ajp.143.1.35","article-title":"The overt aggression scale for the objective rating of verbal and physical aggression","volume":"143","author":"Yudofsky","year":"1986","journal-title":"American Journal of Psychiatry"}],"updated-by":[{"DOI":"10.1002\/14651858.cd008559.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T00:00:00Z","timestamp":1502236800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD008559.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:21:29Z","timestamp":1628533289000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD008559.pub2"}},"subtitle":[],"editor":[{"given":"Jik H","family":"Loy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,9,12]]},"references-count":98,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008559.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717958427.793464682","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2012,9,12]]}}}